Literature DB >> 16722230

Structure/function relationships in serotonin transporter: new insights from the structure of a bacterial transporter.

G Rudnick1.   

Abstract

Serotonin transporter (SERT) serves the important function of taking up serotonin (5-HT) released during serotonergic neurotransmission. It is the target for important therapeutic drugs and psychostimulants. SERT catalyzes the influx of 5-HT together with Na+ and Cl- in a 1:1:1 stoichiometry. In the same catalytic cycle, there is coupled efflux of one K+ ion. SERT is one member of a large family of amino acid and amine transporters that is believed to utilize similar mechanisms of transport. A bacterial member of this family was recently crystallized, revealing the structural basis of these transporters. In light of the new structure, previous results with SERT have been re-interpreted, providing new insight into the substrate binding site, the permeation pathway, and the conformational changes that occur during the transport cycle.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16722230     DOI: 10.1007/3-540-29784-7_3

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  11 in total

1.  Real-time, spatially resolved analysis of serotonin transporter activity and regulation using the fluorescent substrate, ASP+.

Authors:  Murat Oz; Therissa Libby; Bronwyn Kivell; Vanaja Jaligam; Sammanda Ramamoorthy; Toni S Shippenberg
Journal:  J Neurochem       Date:  2010-05-26       Impact factor: 5.372

2.  Threonine 67 is a key component in the coupling of the NSS amino acid transporter KAAT1.

Authors:  M Giovanola; A Vollero; R Cinquetti; E Bossi; L R Forrest; E S Di Cairano; M Castagna
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-01-31       Impact factor: 3.747

Review 3.  Serotonergic targets for the treatment of L-DOPA-induced dyskinesia.

Authors:  Kathryn Lanza; Christopher Bishop
Journal:  J Neural Transm (Vienna)       Date:  2018-01-05       Impact factor: 3.575

Review 4.  How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Authors:  Dennis L Murphy; Meredith A Fox; Kiara R Timpano; Pablo R Moya; Renee Ren-Patterson; Anne M Andrews; Andrew Holmes; Klaus-Peter Lesch; Jens R Wendland
Journal:  Neuropharmacology       Date:  2008-09-11       Impact factor: 5.250

5.  An intracellular interaction network regulates conformational transitions in the dopamine transporter.

Authors:  Julie Kniazeff; Lei Shi; Claus J Loland; Jonathan A Javitch; Harel Weinstein; Ulrik Gether
Journal:  J Biol Chem       Date:  2008-04-21       Impact factor: 5.157

6.  GABA transporter lysine 448: a key residue for tricyclic antidepressants interaction.

Authors:  Francesca Cherubino; Andreea Miszner; Maria Daniela Renna; Rachele Sangaletti; Stefano Giovannardi; Elena Bossi
Journal:  Cell Mol Life Sci       Date:  2009-12       Impact factor: 9.261

7.  Involvement of serotonin transporter extracellular loop 1 in serotonin binding and transport.

Authors:  Yuxin Mao; Leslie Mathewson; Joan Gesmonde; Yuichiro Sato; Marion Holy; Harald H Sitte; Gary Rudnick
Journal:  Mol Membr Biol       Date:  2008-02       Impact factor: 2.857

8.  Fluoxetine treatment abolishes the in vitro respiratory response to acidosis in neonatal mice.

Authors:  Nicolas Voituron; Yuri Shvarev; Clément Menuet; Michelle Bevengut; Caroline Fasano; Erika Vigneault; Salah El Mestikawy; Gérard Hilaire
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

9.  The monoaminergic pathways and inhibition of monoamine transporters interfere with the antidepressive-like behavior of ketamine.

Authors:  Glauce Socorro de Barros Viana; Cecilia Coelho Xavier; Eduardo Mulato do Vale; Maria Janice Pereira Lopes; Viviane de Jesus Alves; Roberta de Oliveira Costa; Kelly Rose Tavares Neves
Journal:  IBRO Rep       Date:  2017-12-02

10.  Identification of a de novo FOXP1 mutation and incidental discovery of inherited genetic variants contributing to a case of autism spectrum disorder and epilepsy.

Authors:  Kristy Jay; Amit Mitra; Taylor Harding; David Matthes; Brian Van Ness
Journal:  Mol Genet Genomic Med       Date:  2019-05-20       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.